CS Paper Radar

HiSTOR: Structured Treatment-outcome Representation Learning for High-Dimensional Longitudinal Data

Chuanqi Lao, Junzhou Huang, Qiao Liu

cs.LG cs.AI ·submitted 2026-10-13 05:17 UTC · v1

Abstract

Estimating potential outcomes under alternative treatment sequences is essential for personalized decision-making, but remains challenging with high-dimensional covariates and time-varying confounding. In this study, we propose HiSTOR (High-dimensional Structured Treatment-Outcome Representation), an end-to-end framework that integrates nonlinear dimension reduction with longitudinal counterfactual prediction. The central idea is to learn structured low-dimensional representations of both current patient states and evolving histories, according to their shared and distinct relationships with treatment assignment and outcomes. This extends latent-space covariate adjustment to longitudinal settings, jointly addressing covariate dimensionality and historical complexity. The resulting framework supports one-step and multi-step outcome prediction under specified treatment sequences. Experiments on CVSim and CancerSim demonstrate the superiority of HiSTOR across varying covariate dimensions, confounding strengths, and prediction horizons compared to state-of-the-art methods. To sum up, HiSTOR offers a unified approach to connecting high-dimensional covariate adjustment with longitudinal potential-outcome prediction.

Closest papers

Nearest neighbours by meaning across the whole index.

PerturbRx: Learning Treatment-Conditioned Latent Transitions for Patient Drug Response Prediction

cs.LG q-bio.QM ·2026-08-21 ·Yoshitaka Inoue, Minoh Jeong, Alfred Hero, Rui Kuang, Augustin Luna
similarity 0.71
Abstract

Scarce data and tumor heterogeneity limit patient-level cancer treatment-response prediction. Existing approaches predict response from pretreatment molecular profiles and drug representations, without explicitly modeling the molecular changes expected under treatment. We propose PerturbRx, a treatment-conditioned representation learning framework that learns intervention-induced latent transitions and uses them as patient-drug response features. PerturbRx trains a drug- and dose-conditioned transition predictor from context-matched but cell-unpaired control and treated single-cell populations, then freezes and transfers the predictor to pretreatment patient profiles without requiring post-treatment measurements. The transition is combined with patient and drug representations to predict response. Across TCGA and patient-derived xenograft benchmarks, PerturbRx achieves the strongest aggregate predictive performance among the evaluated methods. These results support perturbation-pretrained latent transitions as useful representations for patient-level drug-response prediction.

0.25

DeepAJM: Deep Association Joint Model for Irregularly Sampled data

cs.AI stat.APcs.LGstat.ML ·2026-10-05 ·Barsha Halder, Jeffrey A. Thompson
similarity 0.68
Abstract

Joint Models simultaneously model longitudinal and survival outcomes, leveraging patterns in patients' longitudinal trajectory to improve the prediction of survival outcomes. The classical parametric joint models, however, rely on fixed parametric assumptions, making them susceptible to bias under model misspecification and smaller sample sizes. We propose a deep joint model, DeepAJM, that does not require any parametric assumptions, while retaining a partially interpretable, per-longitudinal-outcome association structure. The joint model uses an encoder-decoder (sequence-to-sequence) architecture to learn the latent structure in patients' time-varying covariate trajectories. The model links the longitudinal processes to the survival processes through a learned interpretable association structure, in which each longitudinal output from the decoder gets remodulated by baseline covariates before it contributes to the risk scores from the survival head of the architecture. The model was evaluated on three datasets ( a cardiovascular-disease EHR cohort, a primary biliary cirrhosis (PBC2) dataset, and a simulated dataset) against a classical parametric joint model, TransformerJM, DA-LSTM and a Cox-based survival-only model. All models were assessed using C-index, integrated brier score (IBS), time-dependent AUROC, and time-dependent AUPRC. Our model achieved the best discrimination in terms of the C-index, time-dependent AUROC, and AUPRC across all datasets.

0.23

Representation Learning for Sample-Efficient CATE Estimation by Leveraging Multiple Outcomes

cs.LG ·2026-09-05 ·Maitreyi Swaroop, Shikha Bhat, Samantha Rodriguez, Tamar Krishnamurti, Bryan Wilder
theory similarity 0.67
Abstract

Estimating conditional average treatment effects (CATE) enables efficient targeting of interventions, but many applications have limited experimental samples, making it difficult to estimate heterogeneous effects from high-dimensional covariates. In such settings, policymakers and medical practitioners often succumb to the curse of dimensionality or apply off-the-shelf dimension reduction methods that may not preserve treatment heterogeneity. Yet these domains often come with large historical datasets measuring a wide range of outcomes -- a source of supervision that is rarely exploited in practice. Following causal representation learning, we hypothesize that such domains with high-dimensional covariates have lower-dimensional underlying dynamics. We can thus leverage the diverse outcomes measured in historical data to learn a lower-dimensional representation of the covariates. Theoretically, we prove that when the auxiliary outcomes satisfy a set of surrogacy conditions and the representation retains relevant covariate information, the original CATE is identified when the high-dimensional covariates are replaced by the learned representation. Combined with existing dimension-dependent rates for CATE estimation, the result implies greater sample-efficiency on the same experimental sample. Additionally, we characterize the bias-variance tradeoff when the assumptions do not hold perfectly, and show that the representation-based estimator can still achieve lower error when the reduction in estimator variance outweighs the bias due to compression. Empirically, we evaluate the method on synthetic data and semi-synthetic medical data.

0.21

DynSurvX: Time-Resolved Explanations for Dynamic Survival Predictions

cs.LG ·2026-11-16 ·Van Tuan Nguyen, Agathe Guilloux
top venue similarity 0.67
Abstract

Recent survival models integrating longitudinal data achieve strong predictive performance, but their predictions are often difficult to interpret, limiting their clinical use. We propose DynSurvX, a model-agnostic explainability framework for dynamic survival prediction with mixed static and longitudinal covariates. Based on Shapley values, DynSurvX introduces a hierarchical two-phase strategy that first identifies influential longitudinal features and then adaptively refines their temporal importance, enabling fine-grained explanations while reducing computational cost. The framework provides time-resolved explanations that evolve as new patient data become available. Experiments on simulated and two clinical datasets show varying agreement with theoretical importance across prediction models, with closer agreement for better-performing models, alongside clinically interpretable insights in real-world settings. It remains robust across prediction settings and reduces computation time by 41--80\% relative to the temporal explanation baseline, making dynamic explanations practical.

0.28

A Foundation Model for Policy In-Context Longitudinal Causal Effect Estimation

cs.AI ·2026-10-23 ·Wenxin Chen, Kyra Gan, Mingyu Lu, Zilin Jing, Fei Wang +3 more
similarity 0.67
Abstract

Longitudinal causal effect estimation is complicated by time-varying confounding and treatment-confounder feedback loops. Existing methods generally require data-specific nuisance-model fitting, and many are tailored to prespecified treatment sequences or prediction horizons, leading to time-consuming computation at deployment. We introduce *Policy In-Context Longitudinal causal Effect estimation with Prior-data Fitted Networks* (**PICLE-PFN**), the first foundation model for longitudinal causal effect estimation that supports *dynamic* treatment policies. PICLE-PFN represents target policies through in-context history-decision demonstrations, providing a unified interface for a broad class of treatment policies. Pretrained over synthetic data sampled from longitudinal structural causal models, PICLE-PFN amortizes causal effect estimation across datasets, policies, and horizons. Given a new observational dataset and target policy, it directly predicts conditional average potential outcomes (CAPOs) in one forward pass without task-specific training or hyperparameter tuning. Across synthetic and semi-synthetic longitudinal benchmarks, PICLE-PFN achieves competitive RMSE and substantially improved uncertainty calibration with a fraction of deployment runtime, compared to state-of-the-art conventional estimators trained and tuned separately for each dataset.

0.13

A Multimodal Foundation Model for Longitudinal Patient Representation and Scalable Insight Generation in Oncology

cs.LG ·2026-08-25 ·Eugene Vorontsov, Yi Kan Wang, Alican Bozkurt, Adam Casson, Ludmila Tydlitatova +11 more
similarity 0.66
Abstract

Precision oncology necessitates a longitudinal model of patient state that captures cancer evolution and treatment over time, integrating multimodal observations. We introduce the oFM, a foundation model developed on a real-world oncology cohort of 1.67 million cancer patients that integrates clinical trajectories with DNA, RNA, and H&E pathology. Patient-level partitions were reserved for training, validation, and testing, with over one million patients used for training. The oFM encodes daily clinical and molecular episodes and, along with pathology images, integrates them over time to produce a patient state embedding. We evaluate frozen oFM embeddings against expert-curated clinical and molecular baseline features. In prognostic benchmarks, the oFM improved AUC for treatment response, progression-free survival, and overall survival (0.774 vs. 0.563 for overall survival). Across 11 comparative-treatment cohorts, the oFM embeddings achieved a three-fold higher pooled and scale-normalized treatment-benefit AUTOC than baseline features with improved benefit ranking in 9 of 11 cohorts, and provided stronger prognostic discrimination within both treatment arms. We also evaluated a mechanism discovery framework that interprets downstream models built on oFM embeddings by linking their predicted outcomes to clinically and biologically grounded mechanisms through an evidence-grounded temporal graph, enabling evaluation in clinical and drug-development applications.

0.09

CACSurv: Concordance-Aligned Comparative Learning with Large Language Models for Cancer Survival Prediction

cs.AI ·2026-08-17 ·Tianqi Xiang, Qixiang Zhang, Xinpeng Ding, Yi Li, Xiaomeng Li
benchmarkcode/data similarity 0.66
Abstract

Cancer survival prediction supports treatment planning, risk stratification, and follow-up management. Existing methods use structured clinical variables, whole-slide images, genomic profiles, or multimodal inputs, while patient reports remain underexplored. We study report-centric survival prediction using reports that organize pathological, clinical, and molecular evidence. Large language models (LLMs) can reason over such reports, but case-wise time regression introduces two mismatches. First, a formulation mismatch arises because survival evaluation depends on ordering comparable patients, whereas independent time predictions do not enforce ranking consistency. Second, a supervision mismatch arises because a censored patient's observed time indicates survival beyond that point and cannot serve as an exact regression target, although it still implies orderings relative to patients who died earlier. To address these mismatches, we propose CACSurv, a Concordance-Aligned Comparative framework for report-centric survival prediction. CACSurv reformulates survival modeling as mini-cohort comparative reasoning, where an LLM predicts relative prognostic orderings. We introduce concordance-aligned rewards derived from comparable relations under right censoring, enabling censored outcomes to provide ranking supervision without exact event-time targets. At inference, Monte Carlo Reference Aggregation compares each patient with sampled references and aggregates positions into a cohort-level ranking. We establish TCGA-SurvReport, a benchmark covering six TCGA cancer cohorts. CACSurv achieves the highest C-index on all six cohorts and an average C-index of 0.722, outperforming the strongest published survival model by 6.5 percentage points and the strongest LLM time-regression baseline by 4.2 percentage points. Our code, models, and dataset will be available at https://github.com/xmed-lab/CACSurv.

0.52

CoRe-WM: Conditioned Response-State World Modeling for Longitudinal Treatment-Response Prediction in Breast DCE-MRI

cs.CV ·2026-10-18 ·Lin Zhao, Bowen Chen, Qiaohui Gao, Shaowen Wan, Xiang Li +2 more
similarity 0.65
Abstract

Pathologic complete response (pCR) after neoadjuvant chemotherapy is a key prognostic indicator in aggressive breast cancer, yet existing prediction approaches either rely on pretreatment imaging alone, missing the patient's evolving response, or optimize multi-visit classifiers under direct outcome supervision, coupling representation learning with the clinical endpoint. We formulate longitudinal pCR prediction as a world-modeling problem and propose Conditioned Response-state World Modeling (CoRe-WM), which learns a latent state-transition model that predicts the next imaging state from the observed sequence. The transition function is conditioned on patient clinical profile and assigned therapy through additive shift and feature-wise modulation, enabling patient- and treatment-specific dynamics. A Factorized Response State pathway further decouples treatment-response dynamics from imaging appearance by encoding the structural prior that response manifests primarily in lesion morphology. After pretraining, all parameters are frozen and a linear readout predicts pCR at each clinical decision point. We evaluate CoRe-WM on I-SPY2 under five-fold cross-validation and assess cross-cohort transfer on I-SPY1. CoRe-WM achieves the highest discrimination among all evaluated methods at every prospective decision point, and demonstrates robust cross-cohort transfer. Ablation studies identify patient-profile conditioning and the factorized response pathway as the principal contributors. These results establish world-model-based representation learning as a promising framework for outcome prediction in oncology and beyond.

0.20